Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: Comparison with the Mycobacteria Growth Indicator Tube (MGIT) system

Svetoslav Bardarov, Horng Dou, Katherine Eisenach, Niaz Banaiee, Su Ya, John Chan, William R. Jacobs, Paul F. Riska

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Rapid diagnosis of drug-resistant M.tuberculosis (Mtb) is desirable worldwide. We (i) describe a new luciferase reporter phage (LRP), phAE142 for this purpose; (ii) compare it to the automated MGIT 960 for time-to-detection of Mtb in clinical specimens; and (iii) evaluate its use for species confirmation and antibiotic susceptibility testing(AST) of Mtb. Twenty sputum samples were inoculated for testing by LRP, or by MGIT 960. After "positives" were identified by either method, the LRP was used for confirmation of Mtb complex (TBC) and for AST. The LRP method proved comparably efficient to MGIT 960 at detecting Mtb. Using an antibiotic uniquely inhibiting TBC with LRP provided species assignment, concurrently with AST, in a median of 3 days, with a sensitivity of 97%. Overall agreement in susceptibility results was 96%. Reliable susceptibility results and identification of TBC can be completed in a median of 12 days (range 8 to 16d) with LRP applied to sputum samples.

Original languageEnglish (US)
Pages (from-to)53-61
Number of pages9
JournalDiagnostic Microbiology and Infectious Disease
Volume45
Issue number1
DOIs
StatePublished - Feb 1 2003

Fingerprint

Mycobacterium
Sputum
Luciferases
Bacteriophages
Tuberculosis
Growth
Pharmaceutical Preparations
Anti-Bacterial Agents
Multidrug-Resistant Tuberculosis

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Virology
  • Parasitology
  • Microbiology
  • Immunology
  • Applied Microbiology and Biotechnology

Cite this

@article{4d843460d4674eba8bb5aa3b3855ec00,
title = "Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: Comparison with the Mycobacteria Growth Indicator Tube (MGIT) system",
abstract = "Rapid diagnosis of drug-resistant M.tuberculosis (Mtb) is desirable worldwide. We (i) describe a new luciferase reporter phage (LRP), phAE142 for this purpose; (ii) compare it to the automated MGIT 960 for time-to-detection of Mtb in clinical specimens; and (iii) evaluate its use for species confirmation and antibiotic susceptibility testing(AST) of Mtb. Twenty sputum samples were inoculated for testing by LRP, or by MGIT 960. After {"}positives{"} were identified by either method, the LRP was used for confirmation of Mtb complex (TBC) and for AST. The LRP method proved comparably efficient to MGIT 960 at detecting Mtb. Using an antibiotic uniquely inhibiting TBC with LRP provided species assignment, concurrently with AST, in a median of 3 days, with a sensitivity of 97{\%}. Overall agreement in susceptibility results was 96{\%}. Reliable susceptibility results and identification of TBC can be completed in a median of 12 days (range 8 to 16d) with LRP applied to sputum samples.",
author = "Svetoslav Bardarov and Horng Dou and Katherine Eisenach and Niaz Banaiee and Su Ya and John Chan and Jacobs, {William R.} and Riska, {Paul F.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S0732-8893(02)00478-9",
language = "English (US)",
volume = "45",
pages = "53--61",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage

T2 - Comparison with the Mycobacteria Growth Indicator Tube (MGIT) system

AU - Bardarov, Svetoslav

AU - Dou, Horng

AU - Eisenach, Katherine

AU - Banaiee, Niaz

AU - Ya, Su

AU - Chan, John

AU - Jacobs, William R.

AU - Riska, Paul F.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Rapid diagnosis of drug-resistant M.tuberculosis (Mtb) is desirable worldwide. We (i) describe a new luciferase reporter phage (LRP), phAE142 for this purpose; (ii) compare it to the automated MGIT 960 for time-to-detection of Mtb in clinical specimens; and (iii) evaluate its use for species confirmation and antibiotic susceptibility testing(AST) of Mtb. Twenty sputum samples were inoculated for testing by LRP, or by MGIT 960. After "positives" were identified by either method, the LRP was used for confirmation of Mtb complex (TBC) and for AST. The LRP method proved comparably efficient to MGIT 960 at detecting Mtb. Using an antibiotic uniquely inhibiting TBC with LRP provided species assignment, concurrently with AST, in a median of 3 days, with a sensitivity of 97%. Overall agreement in susceptibility results was 96%. Reliable susceptibility results and identification of TBC can be completed in a median of 12 days (range 8 to 16d) with LRP applied to sputum samples.

AB - Rapid diagnosis of drug-resistant M.tuberculosis (Mtb) is desirable worldwide. We (i) describe a new luciferase reporter phage (LRP), phAE142 for this purpose; (ii) compare it to the automated MGIT 960 for time-to-detection of Mtb in clinical specimens; and (iii) evaluate its use for species confirmation and antibiotic susceptibility testing(AST) of Mtb. Twenty sputum samples were inoculated for testing by LRP, or by MGIT 960. After "positives" were identified by either method, the LRP was used for confirmation of Mtb complex (TBC) and for AST. The LRP method proved comparably efficient to MGIT 960 at detecting Mtb. Using an antibiotic uniquely inhibiting TBC with LRP provided species assignment, concurrently with AST, in a median of 3 days, with a sensitivity of 97%. Overall agreement in susceptibility results was 96%. Reliable susceptibility results and identification of TBC can be completed in a median of 12 days (range 8 to 16d) with LRP applied to sputum samples.

UR - http://www.scopus.com/inward/record.url?scp=0037311101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037311101&partnerID=8YFLogxK

U2 - 10.1016/S0732-8893(02)00478-9

DO - 10.1016/S0732-8893(02)00478-9

M3 - Article

C2 - 12573551

AN - SCOPUS:0037311101

VL - 45

SP - 53

EP - 61

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 1

ER -